Nocardia bacteremia: A single-center retrospective review and a systematic review of the literature

Objectives: Nocardia bacteremia is a rare but severe disease associated with high mortality. This systematic review is the largest and most comprehensive review performed over the past 20 years. Methods: A single-center retrospective review of Nocardia bacteremia was performed using hospital microbi...

Full description

Bibliographic Details
Main Authors: Eloise Williams, Adam W. Jenney, Denis W. Spelman
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220300138
id doaj-1d549712d53a4f6c942ce46eb9d3f252
record_format Article
spelling doaj-1d549712d53a4f6c942ce46eb9d3f2522020-11-25T01:45:13ZengElsevierInternational Journal of Infectious Diseases1201-97122020-03-0192197207Nocardia bacteremia: A single-center retrospective review and a systematic review of the literatureEloise Williams0Adam W. Jenney1Denis W. Spelman2Microbiology Unit, Alfred Health, 55 Commercial Rd, Melbourne, Victoria, Australia; Department of Infectious Diseases, Alfred Health, 55 Commercial Rd, Melbourne, Victoria, Australia; Corresponding author at: Microbiology Unit, Austin Health, 145 Studley Rd, Heidelberg, Victoria, Australia.Microbiology Unit, Alfred Health, 55 Commercial Rd, Melbourne, Victoria, Australia; Department of Infectious Diseases, Alfred Health, 55 Commercial Rd, Melbourne, Victoria, Australia; Department of Infectious Diseases, Monash University, Melbourne, Victoria, AustraliaMicrobiology Unit, Alfred Health, 55 Commercial Rd, Melbourne, Victoria, Australia; Department of Infectious Diseases, Alfred Health, 55 Commercial Rd, Melbourne, Victoria, Australia; Department of Infectious Diseases, Monash University, Melbourne, Victoria, AustraliaObjectives: Nocardia bacteremia is a rare but severe disease associated with high mortality. This systematic review is the largest and most comprehensive review performed over the past 20 years. Methods: A single-center retrospective review of Nocardia bacteremia was performed using hospital microbiology records from January 1, 2010 to December 31, 2017. A systematic literature review was also performed to identify cases of Nocardia bacteremia described in the NCBI PubMed database in English between January 1, 1999 and December 31, 2018. Results: Four new cases of Nocardia bacteremia are described. The systematic review identified 134 cases with sufficient information available for analysis. Of the total 138 cases, the median age was 58 years (interquartile range (IQR) 44–69 years) and 70% were male. Eighty-one percent were immunocompromised (corticosteroid use (49%), hematological malignancy (20%), solid organ transplant (20%), solid organ malignancy (19%), and hematopoietic stem cell transplantation (15%)) and 29% had endovascular devices. Pulmonary infection was the most common concurrent site of clinical disease (67%). The median incubation time to the detection of Nocardia bacteremia was 4 days (IQR 3–6 days). Blood cultures were the only positive microbiological specimen in 38% of cases. The median total duration of treatment was 75 days (IQR 25–182 days). Thirty-day all-cause mortality was 28% and overall all-cause mortality was 40%. Conclusions: Nocardia bacteremia is most frequently identified in immunocompromised patients and those with intravascular devices. Although rare, it represents a serious infection with high associated overall mortality. Keywords: Nocardia, Nocardiosis, Bacteremia, Central line-associated bloodstream infection, Immunocompromisehttp://www.sciencedirect.com/science/article/pii/S1201971220300138
collection DOAJ
language English
format Article
sources DOAJ
author Eloise Williams
Adam W. Jenney
Denis W. Spelman
spellingShingle Eloise Williams
Adam W. Jenney
Denis W. Spelman
Nocardia bacteremia: A single-center retrospective review and a systematic review of the literature
International Journal of Infectious Diseases
author_facet Eloise Williams
Adam W. Jenney
Denis W. Spelman
author_sort Eloise Williams
title Nocardia bacteremia: A single-center retrospective review and a systematic review of the literature
title_short Nocardia bacteremia: A single-center retrospective review and a systematic review of the literature
title_full Nocardia bacteremia: A single-center retrospective review and a systematic review of the literature
title_fullStr Nocardia bacteremia: A single-center retrospective review and a systematic review of the literature
title_full_unstemmed Nocardia bacteremia: A single-center retrospective review and a systematic review of the literature
title_sort nocardia bacteremia: a single-center retrospective review and a systematic review of the literature
publisher Elsevier
series International Journal of Infectious Diseases
issn 1201-9712
publishDate 2020-03-01
description Objectives: Nocardia bacteremia is a rare but severe disease associated with high mortality. This systematic review is the largest and most comprehensive review performed over the past 20 years. Methods: A single-center retrospective review of Nocardia bacteremia was performed using hospital microbiology records from January 1, 2010 to December 31, 2017. A systematic literature review was also performed to identify cases of Nocardia bacteremia described in the NCBI PubMed database in English between January 1, 1999 and December 31, 2018. Results: Four new cases of Nocardia bacteremia are described. The systematic review identified 134 cases with sufficient information available for analysis. Of the total 138 cases, the median age was 58 years (interquartile range (IQR) 44–69 years) and 70% were male. Eighty-one percent were immunocompromised (corticosteroid use (49%), hematological malignancy (20%), solid organ transplant (20%), solid organ malignancy (19%), and hematopoietic stem cell transplantation (15%)) and 29% had endovascular devices. Pulmonary infection was the most common concurrent site of clinical disease (67%). The median incubation time to the detection of Nocardia bacteremia was 4 days (IQR 3–6 days). Blood cultures were the only positive microbiological specimen in 38% of cases. The median total duration of treatment was 75 days (IQR 25–182 days). Thirty-day all-cause mortality was 28% and overall all-cause mortality was 40%. Conclusions: Nocardia bacteremia is most frequently identified in immunocompromised patients and those with intravascular devices. Although rare, it represents a serious infection with high associated overall mortality. Keywords: Nocardia, Nocardiosis, Bacteremia, Central line-associated bloodstream infection, Immunocompromise
url http://www.sciencedirect.com/science/article/pii/S1201971220300138
work_keys_str_mv AT eloisewilliams nocardiabacteremiaasinglecenterretrospectivereviewandasystematicreviewoftheliterature
AT adamwjenney nocardiabacteremiaasinglecenterretrospectivereviewandasystematicreviewoftheliterature
AT deniswspelman nocardiabacteremiaasinglecenterretrospectivereviewandasystematicreviewoftheliterature
_version_ 1725024311939432448